Correction: Mol Cancer 23, 282 (2024)
10.1186/s12943-024-02180-y
Following the publication of the original article [1], the authors reported that they identified an inadvertent duplication of images labeled GDSC and CTRP in the Fig. 2O, and wish to formally request an erratum to rectify this issue. In the correct Fig. 2, they have replaced the correct Fig. 2O. They are confident that the inadvertent panel duplication did not have any effect on their analyses or on any conclusions drawn from the paper, and they apologize for the error.
Incorrect Fig. 2:
Correct Fig. 2:
Footnotes
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Xing Zhou, Jiashu Han, Anning Zuo, Yuhao Ba and Shutong Liu contributed equally to this work and share first authorship.
Contributor Information
Xinwei Han, Email: fcchanxw@zzu.edu.cn.
Jinhai Deng, Email: jinhaideng_kcl@163.com.
Zaoqu Liu, Email: liuzaoqu@163.com.
References
- 1.Zhou X, Han J, Zuo A, et al. THBS2 + cancer-associated fibroblasts promote EMT leading to oxaliplatin resistance via COL8A1-mediated PI3K/AKT activation in colorectal cancer. Mol Cancer. 2024;23:282. 10.1186/s12943-024-02180-y. [DOI] [PMC free article] [PubMed] [Google Scholar]